Back when the Fact Checker covered politics, “person in the street” interviews generally yielded a similar answer when people were asked about the government — and whether they got much in benefits for the taxes they pay. The common response: It’s a raw deal for me. So we were struck by Barrasso’s comment. Are folks really getting $3 in benefits for every $1 in taxes they have paid? And is this really the right way to look at this statistic?
The Facts: Barrasso spokeswoman Emily Lawrimore said that Barrasso obtained this statistic from a report published by the nonpartisan Urban Institute, written by C. Eugene Steuerle and Caleb Quakenbush. The report tracked Social Security and Medicare taxes and benefits over a lifetime, for a variety of scenarios, and is embedded below. (For interested readers, Urban also has posted a Q-and-A on how the calculations were made.)
Read the full story: http://wapo.st/Yp6zbX
Source: Kaiser Health News
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Poor Well-Being Scores Linked to Early Treatment Stoppage in Multiple Myeloma
March 27th 2024Investigators used the Functional Assessment of Cancer Therapy-General General Physical Wellbeing Scale to collect data on patient-reported treatment-related adverse effects, to provide clinicians guidance on predicting risk of early treatment discontinuation among ECOG-ACRIN E1A11 trial participants.
Read More